相关实验视频
Updated: Jul 24, 2025

Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
阿戈梅拉丁通过 Melatonin 受体依赖和独立的机制抑制血小板聚合
Julia Modesto Vicente1, Caroline Honaiser Lescano1, Silvana Bordin2
1Department of Translational Medicine, School of Medical Sciences, State University of Campinas, Campinas, Brazil.
阿戈梅拉丁 (Ago) 降低了人体血小板的聚合和粘附,可能防止动脉血事件. 这种抗抑郁药是抗抑郁药.
科学领域:
- 药理学 药理学是指药理学的学科.
- 血液学 血液学 血液学
- 心血管研究研究心血管研究
背景情况:
- 黑色素抑制了血小板的聚合.
- 阿戈梅拉丁 (Ago) 是一种具有MT1和MT2受体agonist活性的抗抑郁药.
研究的目的:
- 调查阿戈梅拉丁 (Ago) 是否降低了血小板聚合和粘附.
- 确定黑激素受体 (MT1/MT2) 在Ago对血小板的影响中的作用.
主要方法:
- 在体外测试来自健康捐献者的人类血小板.
- 进行了聚合,粘附,血栓素B2 (TxB2),cAMP,cGMP,细胞内和流细胞计测试.
- 利用MT1/MT2对抗剂和激动剂来阐明受体参与.
主要成果:
- 阿戈梅拉丁抑制了阿拉基酸 (AA) 和原诱导的血小板聚合.
- 阿戈减少了AA诱导的TxB2产生,水平和P-选择素表达.
- MT1受体激活介导了Ago对AA刺激血小板的影响,而MT2受体参与对AA不太清楚,对原体没有观察到.
结论:
- 阿戈梅拉丁抑制了人类的血小板聚合.
- 阿戈可以通过抑制血栓形成和血管封闭来预防动脉血栓性缺血事件.
更多相关视频
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
06:42A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice
Published on: April 16, 2018
相关概念视频
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Management of Insomnia
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Antidepressant Drugs: MAOIs and Other Agents
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Drugs Affecting Neurotransmitter Release or Uptake